Altimmune Inc [NASDAQ: ALT] closed the trading session at $8.05.
The stocks have a year to date performance of -28.44 percent and weekly performance of -15.44 percent. The stock has been moved at 2.03 percent over the last six months. The stock has performed 18.38 percent around the most recent 30 days and changed 19.08 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 2.67M shares, ALT reached to a volume of 4744446 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Altimmune Inc [ALT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ALT shares is $21.25 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALT stock is a recommendation set at 1.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Altimmune Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 12, 2024. The new note on the price target was released on April 29, 2024, representing the official price target for Altimmune Inc stock. Previously, the target price had yet another raise to $13, while Goldman analysts kept a Neutral rating on ALT stock. On March 22, 2023, analysts decreased their price target for ALT shares from 20 to 6.
The Average True Range (ATR) for Altimmune Inc is set at 0.77, with the Price to Sales ratio for ALT stock in the period of the last 12 months amounting to 11451.04. The Price to Book ratio for the last quarter was 4.29, with the Price to Cash per share for the same quarter was set at 1.96.
ALT stock trade performance evaluation
Altimmune Inc [ALT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.44. With this latest performance, ALT shares gained by 18.38% in over the last four-week period, additionally plugging by 2.03% over the last 6 months – not to mention a rise of 206.08% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ALT stock in for the last two-week period is set at 55.76, with the RSI for the last a single of trading hit 55.33, and the three-weeks RSI is set at 55.62 for Altimmune Inc [ALT]. The present Moving Average for the last 50 days of trading for this stock 7.06, while it was recorded at 7.75 for the last single week of trading, and 7.59 for the last 200 days.
Altimmune Inc [ALT]: An insightful look at the core fundamentals
Altimmune Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 16.87 and a Current Ratio set at 16.87.
Earnings per share (EPS) analysis for Altimmune Inc [ALT] stock
With the latest financial reports released by the company, Altimmune Inc posted -0.33/share EPS, while the average EPS was predicted by analysts to be reported at -0.38/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.05. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ALT.
Altimmune Inc [ALT]: Institutional Ownership
There are presently around $56.56%, or 57.02%% of ALT stock, in the hands of institutional investors. The top three institutional holders of ALT stocks are: BLACKROCK INC. with ownership of 5.32 million shares, which is approximately 7.5155%. VANGUARD GROUP INC, holding 4.91 million shares of the stock with an approximate value of $$32.63 million in ALT stocks shares; and VANGUARD GROUP INC, currently with $$26.0 million in ALT stock with ownership which is approximately 5.5215%.
